SUMMIT European Cannabis Insights Summit 2026 — Exclusive industry intelligence Register Now
EVENT Cannabis Europa London 2026 — Europe's cannabis industry unites Get Tickets

Recent Searches

    Connecticut prosecutors drop over 1,500 marijuana cases in expansion of legalization reliefa

    By
    CONNECTICUT

    Connecticut prosecutors drop over 1,500 marijuana cases in expansion of legalization relief

    Connecticut prosecutors have dismissed more than 1,500 pending marijuana cases, while modifying about 600 others, reports Marijuana Moment.

    The development follows a review as part of the state’s post-legalization criminal erasure program, which involved individualized examinations of 4,248 cases involving controlled substances.

    A letter to lawmakers stated:  “With 4,248 cases statewide containing this charge (2,139 pending and 2,109 in re-arrest status) this was no small task, and quite labor intensive.

    “Nonetheless, given the Committee’s expressed concerns, I represented to you that resolving these cases would be treated as a priority by the Division without the need for further legislation in this area.”

    US PROGRESS

    Cannabis legalization update: Minnesota, Michigan, Montana, Maryland, Connecticut & Florida

    Benzinga provides an overview of the latest cannabis developments in the US.

    In Minnesota, cannabis is close to legalization after a Senate committee approved a bill by Sen. Lindsey Port (D)., whereas in Maryland, the state Senate Finance Committee voted 5-3 against labor peace agreements as a licensure requirement for the industry.

    In Montana, lawmakers are debating two legislative proposals that have different goals and perspectives on how to distribute cannabis tax revenue, and in Wethersfield, Connecticut, its Planning and Zoning Commission has approved a proposal for recreational cannabis sales on March 21, 2023.

    Finally, Michigan will be holding the 4th Annual Cannabis Cup with more categories, brands and retailers.

    GERMANY

    Germany might pivot to ‘cannabis legalization light’ amid EU pushback

    MJ Biz Daily reports that German officials are considering a “cannabis legalization light” model amid concerns that nationwide legalization could violate European law.

    Instead of its initial plans to legalize, the country may now implement a trial model similar to the one Swiss city of Zurich, under which recreational cannabis sales would be confined to certain parts of the country for three to five years.

    The publication highlights that the suggestion has been put forward on the basis that comprehensive legalization in Germany “is obviously not feasible in the short term” because of European legalities.

    Constantin von der Groeben, managing director of Berlin-headquartered cannabis company Demecan, told MJBizDaily: “We have been expecting this result – a ‘model’ project – for several months and are therefore not surprised. Anything else would have been too difficult to align with EU regulation.”

     

    Stephanie Price

    Stephanie is a journalist for Business of Cannabis, writing about science, research, policy and industry developments in cannabis, CBD and psychedelics. In 2013 Stephanie gained her BA in English and Media, focusing on journalism and propaganda, where her magazine ‘Game Theory’ focused on developments and disruptors over the coming decade including cannabis, psychedelics, blockchain/crypto and free speech. In 2015 Stephanie received her National Council for the Training of Journalists (NCTJ) diploma whilst working as a reporter in North Wales. Stephanie has a specialism in Medical Cannabis: The Health Effects of THC and CBD through the University of Colorado, and a certificate from the Medical Cannabis Clinicians Society on “Medical Cannabis Explained”.

    The Briefing / Newsletter

    Insights
    you don't want
    to miss.

    A comprehensive, thoughtfully curated overview of the stories defining today's cannabis sector — breaking news, investigative features, expert commentary, and context-rich analysis to help you navigate events with clarity and confidence.

    • Policy & regulation
    • Markets & deals
    • Clinical & science
    Subscribe free